Melanoma

Merck advancing breast cancer drug to mid-stage

Drugmaker Merck & Co. said Wednesday that it will advance a new cancer drug into bigger patient tests, after promising findings in an early study against a very aggressive, common type of breast cancer.

Dec 10, 2014
popularity 0 comments 0

Blue-eyed people may face higher melanoma risk

(HealthDay)—New research suggests that genes tied to blue eyes and red hair could put people at higher risk for moles or freckling in childhood, which are often precursors to the deadly skin cancer melanoma ...

Nov 19, 2014
popularity 0 comments 0

Treatments show promise in metastatic melanoma

(HealthDay)—In metastatic melanoma, nivolumab improves overall and progression-free survival versus dacarbazine, and dabrafenib plus trametinib improves survival versus vemurafenib monotherapy, according ...

Nov 18, 2014
popularity 0 comments 0

Latest Spotlight News

Crossing fingers can reduce feelings of pain

How you feel pain is affected by where sources of pain are in relation to each other, and so crossing your fingers can change what you feel on a single finger, finds new UCL research.

HIV can spread early, evolve in patients' brains

The AIDS virus can genetically evolve and independently replicate in patients' brains early in the illness process, researchers funded by the National Institutes of Health have discovered. An analysis of ...